PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J mice

被引:6
作者
Bill, Ruben [1 ]
Doering, Axinia [1 ]
Deutsch, Urban [1 ]
Engelhardt, Britta [1 ]
机构
[1] Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland
关键词
Gene targeted mice; Backcrossing; EAE; Modulatory genes; PSGL-1; SELECTIN GLYCOPROTEIN LIGAND-1; BLOOD-BRAIN-BARRIER; P-SELECTIN; MULTIPLE-SCLEROSIS; T-CELLS; C57BL/6; MICE; ANIMAL-MODEL; NATALIZUMAB;
D O I
10.1016/j.jneuroim.2010.10.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The adhesion molecule P-selectin glycoprotein ligand (PSGL)-1 has been suggested to be involved in the immunopathogenesis of multiple sclerosis (MS). However, in C57BL/6 mice PSGL-1 was found to be dispensible for the development of MOG(aa35-55)-induced experimental autoimmune encephalomyelitis (EAE), an animal model for MS. To study, if involvement of PSGL-1 to EAE pathogenesis can be observed in another common mouse model, we backcrossed PSGL-1(-/-) mice for at least 12 generations into the SJL/J background and compared PLPaa139-151 induced EAE in PSGL-1(-/-) SJL/J mice versus wild-type SJL/J mice. Here, we demonstrate that PSGL-1(-/-) SJL/J mice exhibited EAE pathogenesis indistinguishable from wild-type SJL/J mice. Our present study underscores and emphasizes previous observations that PSGL-1 is dispensible for EAE pathogenesis. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:207 / 208
页数:2
相关论文
共 15 条
[1]   Peripheral blood CD4+T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line [J].
Bahbouhi, Bouchaib ;
Berthelot, Laureline ;
Pettre, Segolene ;
Michel, Laure ;
Wiertlewski, Sandrine ;
Weksler, Babette ;
Romero, Ignacio-Andres ;
Miller, Florence ;
Couraud, Pierre-Olivier ;
Brouard, Sophie ;
Laplaud, David-Axel ;
Soulillou, Jean-Paul .
JOURNAL OF LEUKOCYTE BIOLOGY, 2009, 86 (05) :1049-1063
[2]   Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions [J].
Bartholomaeus, Ingo ;
Kawakami, Naoto ;
Odoardi, Francesca ;
Schlaeger, Christian ;
Miljkovic, Djordje ;
Ellwart, Joachim W. ;
Klinkert, Wolfgang E. F. ;
Fluegel-Koch, Cassandra ;
Issekutz, Thomas B. ;
Wekerle, Hartmut ;
Fluegel, Alexander .
NATURE, 2009, 462 (7269) :94-U104
[3]   CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules:: a critical role for P-selectin glycoprotein ligand-1 [J].
Battistini, L ;
Piccio, L ;
Rossi, B ;
Bach, S ;
Galgani, S ;
Gasperini, C ;
Ottoboni, L ;
Ciabini, D ;
Caramia, MD ;
Bernardi, G ;
Laudanna, C ;
Scarpini, E ;
McEver, RP ;
Butcher, EC ;
Borsellino, G ;
Constantin, G .
BLOOD, 2003, 101 (12) :4775-4782
[4]   Cutting Edge: Natalizumab Blocks Adhesion but Not initial Contact of Human T Cells to the Blood-Brain Barrier In Vivo in an Animal Model of Multiple Sclerosis [J].
Coisne, Caroline ;
Mao, Wenxian ;
Engelhardt, Britta .
JOURNAL OF IMMUNOLOGY, 2009, 182 (10) :5909-5913
[5]   IL-12 driven upregulation of P-selectin ligand on myelin-specific T cells is a critical step in an animal model of autoimmune demyelination [J].
Deshpande, P ;
King, IL ;
Segal, BM .
JOURNAL OF NEUROIMMUNOLOGY, 2006, 173 (1-2) :35-44
[6]   E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice [J].
Doering, Axinia ;
Wild, Martin ;
Vestweber, Dietmar ;
Deutsch, Urban ;
Engelhardt, Britta .
JOURNAL OF IMMUNOLOGY, 2007, 179 (12) :8470-8479
[7]   P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice [J].
Engelhardt, B ;
Kempe, B ;
Merfeld-Clauss, S ;
Laschinger, M ;
Furie, B ;
Wild, MK ;
Vestweber, D .
JOURNAL OF IMMUNOLOGY, 2005, 175 (02) :1267-1275
[8]   E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis [J].
Engelhardt, B ;
Vestweber, D ;
Hallmann, R ;
Schulz, M .
BLOOD, 1997, 90 (11) :4459-4472
[9]   The blood-central nervous system barriers actively control immune cell entry into the central nervous system [J].
Engelhardt, Britta .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (16) :1555-1565
[10]   Natalizumab:: Targeting α4-integrins in multiple sclerosis [J].
Engelhardt, Britta ;
Kappos, Ludwig .
NEURODEGENERATIVE DISEASES, 2008, 5 (01) :16-22